Sabrina Xin Yi Khor

Sabrina Xin Yi Khor

Auto-generated profile, based on publicly available information

Sabrina Xin Yi Khor

School of Biosciences, Faculty of Health and Medical Sciences, Taylor's University, Subang Jaya, Selangor Darul Ehsan, Malaysia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2024 in Protein & Peptide Letters
Verified
Journal Article
Closed access
PDF file
SKSabrina Xin Yi Khor
Sabrina Xin Yi Khor
KKKitiphong Khongphinitbunjong
Kitiphong Khongphinitbunjong
AOAmorn Owatworakit
Amorn Owatworakit
Siau Hui MahSiau Hui Mah
Siau Hui Mah
YTYin Quan Tang
Yin Quan Tang
Cancer is a deadly disease that has claimed millions of lives worldwide. Traditional cancer treatments, such as chemotherapy and radiation, have been used for many years but have become less favored due to drug resistance, lack of tumor selectivity, high costs, and various side effects, such as fatigue and hair loss. Many studies have reported that animal venoms, such as those from snakes, scorpions, and bees, contain bioactive peptides that can be synthesized into anti-- cancer peptides (ACPs), which offer a potential alternative to traditional cancer therapies. Apitherapy is an area of growing interest for the development of new cancer treatments using bee venom, which is a complex mixture of biologically active peptides, enzymes, bioactive amines, and nonpeptide components that have been found to have anti-cancer properties. By leveraging these bioactive peptides, researchers could develop ACPs that are more targeted towards cancer cells, reducing the risk of adverse side effects and improving patient outcomes. The use of bee venom components in targeting cancer could provide a more selective, effective, and affordable approach to cancer therapy. While further research is needed, the potential benefits of using bee venom components in cancer therapy are significant and could help improve the lives of cancer patients worldwide. This study aims to review the components of bee venom as potential cancer treatments.

30 September 2025 in Journal of Medical Science
Verified
Journal Article
Open access
ACAlyssa Pei Qi Chang
Alyssa Pei Qi Chang
SKSabrina Xin Yi Khor
Sabrina Xin Yi Khor
CYChia Yoke Yin
Chia Yoke Yin
SCSunita Chamyuang
Sunita Chamyuang
YTYin Quan Tang
Yin Quan Tang
Introduction. Cordyceps militaris (CM), a traditional medicinal fungus in East Asia, has attracted increasing attention for its anticancer potential. Despite extensive use in traditional medicine, the mechanisms underlying its antimetastatic and antiangiogenic effects in breast cancer remain unclear. This study aimed to explore the bioactive components of aqueous extracts derived from CM’s mycelium (Aq-CMM) and fruiting body (Aq-CMF), focusing on their potential inhibitory activities on metastasis and angiogenesis in triple-negative breast cancer cells (MDA-MB-231). Materials and methods. In silico molecular docking was conducted to screen for key CM bioactive compounds and evaluate their binding affinities toward metastasis- and angiogenesis-related targets, NF-κB and VEGFR. In vitro cytotoxicity was assessed using 2D monolayer and 3D spheroid MDA-MB-231 cultures treated with Aq-CMM and Aq-CMF. Cell viability (IC₅₀) was determined at 48 hours, and microscopic evaluation of treated spheroids was performed to assess morphological disruption. Results and conclusions. Docking analyses identified ergothioneine as a major CM-derived compound with strong binding affinity to NF-κB (−7.83 kcal/mol) and VEGFR (−7.62 kcal/mol), suggesting potent inhibitory effects on metastatic and angiogenic pathways. In vitro assays showed that Aq-CMF exerted greater growth-inhibitory effects (IC₅₀ = 54 µg/mL in 2D; 46 µg/mL in 3D) than Aq-CMM at 48 hours. Microscopic observations confirmed notable disruption of spheroid architecture following treatment. These findings highlight the therapeutic potential of ergothioneine-rich CM extracts, particularly from the fruiting body, as promising anticancer agents that warrant further mechanistic and translational studies.